AR090970A1 - Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico - Google Patents

Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico

Info

Publication number
AR090970A1
AR090970A1 ARP130101563A ARP130101563A AR090970A1 AR 090970 A1 AR090970 A1 AR 090970A1 AR P130101563 A ARP130101563 A AR P130101563A AR P130101563 A ARP130101563 A AR P130101563A AR 090970 A1 AR090970 A1 AR 090970A1
Authority
AR
Argentina
Prior art keywords
cells
pancreatic endoderm
differentiation
embryous
markers indicative
Prior art date
Application number
ARP130101563A
Other languages
English (en)
Spanish (es)
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of AR090970A1 publication Critical patent/AR090970A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • C12N5/0678Stem cells; Progenitor cells; Precursor cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/005Protein-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • C12N5/0672Stem cells; Progenitor cells; Precursor cells; Oval cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/065Modulators of histone acetylation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/19Growth and differentiation factors [GDF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/90Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ARP130101563A 2012-05-07 2013-05-07 Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico AR090970A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261643684P 2012-05-07 2012-05-07

Publications (1)

Publication Number Publication Date
AR090970A1 true AR090970A1 (es) 2014-12-17

Family

ID=49551213

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101563A AR090970A1 (es) 2012-05-07 2013-05-07 Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico

Country Status (17)

Country Link
US (1) US20140162359A1 (enExample)
EP (1) EP2847319A4 (enExample)
JP (1) JP6450674B2 (enExample)
KR (1) KR20150014478A (enExample)
CN (1) CN104284977A (enExample)
AR (1) AR090970A1 (enExample)
AU (1) AU2013259706A1 (enExample)
BR (1) BR112014027783A2 (enExample)
CA (1) CA2872770A1 (enExample)
HK (1) HK1207885A1 (enExample)
IL (1) IL235132A0 (enExample)
IN (1) IN2014DN08561A (enExample)
MX (1) MX2014013524A (enExample)
PH (1) PH12014502686A1 (enExample)
RU (1) RU2668814C2 (enExample)
SG (1) SG11201406884SA (enExample)
WO (1) WO2013169769A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102341674B1 (ko) 2013-06-11 2021-12-22 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 SC-β 세포 및 조성물 그리고 그 생성 방법
CN113234661A (zh) 2014-12-18 2021-08-10 哈佛学院校长同事会 干细胞来源的β细胞的产生方法及其使用方法
US10190096B2 (en) 2014-12-18 2019-01-29 President And Fellows Of Harvard College Methods for generating stem cell-derived β cells and uses thereof
WO2016100898A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof
CN106467918B (zh) * 2015-08-18 2020-07-31 中国科学技术大学先进技术研究院 一种基于人皮肤细胞的胰岛素分泌细胞的诱导方法及应用
US20210147807A1 (en) * 2017-06-14 2021-05-20 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
KR102789149B1 (ko) 2017-11-15 2025-03-31 셈마 테라퓨틱스, 인크. 섬세포 제조 조성물 및 사용 방법
AU2019320072A1 (en) 2018-08-10 2021-02-25 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
US12378572B2 (en) 2018-09-07 2025-08-05 Crispr Therapeutics Ag Universal donor cells
AU2020283056B2 (en) 2019-05-31 2023-06-08 Viacyte, Inc. A biocompatible membrane composite
WO2020243666A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
EP3976237A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. Cell encapsulation devices with controlled oxygen diffusion distances
EP3976236A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates Inc. A biocompatible membrane composite
WO2021044377A1 (en) 2019-09-05 2021-03-11 Crispr Therapeutics Ag Universal donor cells
US11118196B2 (en) 2019-09-05 2021-09-14 Crispr Therapeutics Ag Universal donor cells
WO2022144856A1 (en) 2020-12-31 2022-07-07 Crispr Therapeutics Ag Universal donor cells
CN113046306B (zh) * 2021-03-12 2022-10-18 广东东阳光药业有限公司 一种多能干细胞的培养方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
KR101008868B1 (ko) 2001-12-07 2011-01-17 제론 코포레이션 인간 배아 줄기세포 유래의 섬세포
CN103898045B (zh) 2003-12-23 2019-02-01 维亚希特公司 定形内胚层
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
US8741643B2 (en) * 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
WO2008013664A2 (en) 2006-07-26 2008-01-31 Cythera, Inc. Methods of producing pancreatic hormones
MX2010000348A (es) * 2007-07-01 2010-04-12 Lifescan Inc Cultivo de celulas madre pluripotentes individuales.
ES2537578T3 (es) * 2007-07-18 2015-06-09 Lifescan, Inc. Diferenciación de las células madre de embriones humanos
CA2695225C (en) * 2007-07-31 2021-06-01 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
US7939322B2 (en) * 2008-04-24 2011-05-10 Centocor Ortho Biotech Inc. Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
BRPI0914116A2 (pt) * 2008-06-30 2019-09-17 Centocor Ortho Biotech Inc diferenciação de células-tronco pluripotentes
US20100028307A1 (en) * 2008-07-31 2010-02-04 O'neil John J Pluripotent stem cell differentiation
EP2346988B1 (en) * 2008-10-31 2017-05-31 Janssen Biotech, Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
AU2010276402B2 (en) * 2009-07-20 2014-07-03 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
WO2011058558A2 (en) * 2009-11-12 2011-05-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
EP2542666A4 (en) * 2010-03-02 2014-05-07 Univ Singapore CULTURE ADDITIVES FOR PROMOTING A STEM CELL PROGRAMMING AND DIFFERENTIATION REACTION
CA2793971A1 (en) * 2010-03-23 2011-09-29 Kuraray Co., Ltd. Culture method for causing differentiation of pluripotent mammalian cells
RU2673946C1 (ru) * 2010-08-31 2018-12-03 Янссен Байотек, Инк. Дифференцирование плюрипотентных стволовых клеток

Also Published As

Publication number Publication date
WO2013169769A1 (en) 2013-11-14
CA2872770A1 (en) 2013-11-14
PH12014502686A1 (en) 2015-01-26
RU2668814C2 (ru) 2018-10-02
EP2847319A1 (en) 2015-03-18
JP6450674B2 (ja) 2019-01-09
CN104284977A (zh) 2015-01-14
RU2014149185A (ru) 2016-06-27
IN2014DN08561A (enExample) 2015-05-22
JP2015516161A (ja) 2015-06-11
SG11201406884SA (en) 2014-11-27
IL235132A0 (en) 2014-12-31
BR112014027783A2 (pt) 2017-06-27
MX2014013524A (es) 2015-02-10
KR20150014478A (ko) 2015-02-06
HK1207885A1 (en) 2016-02-12
EP2847319A4 (en) 2015-12-16
US20140162359A1 (en) 2014-06-12
AU2013259706A1 (en) 2014-10-30

Similar Documents

Publication Publication Date Title
AR090970A1 (es) Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico
AR082820A1 (es) Diferenciacion de celulas madre embrionarias humanas
MX2013002405A (es) Diferenciacion de celulas madre embrionarias humanas.
AR089426A1 (es) Diferenciacion de celulas madre embrionarias humanas en celulas hormonales unicas positivas para insulina
AR081040A1 (es) Diferenciacion de celulas madre embrionarias humanas
AR080434A1 (es) Metodo para purificar celulas derivadas de celulas madre pluripotenciales
AR108847A1 (es) GENERACIÓN DE CÉLULAS MADRE PLURIPOTENTES HUMANAS DERIVADAS DE CÉLULAS FUNCIONALES b CON RESPIRACIÓN MITOCONDRIAL DEPENDIENTE DE GLUCOSA Y CON RESPUESTA EN DOS FASES DE SECRECIÓN DE INSULINA
AR094347A1 (es) Cultivo de células madre embrionarias humanas en la interfase aire-líquido para la diferenciación en células endocrinas pancreáticas
BR112012015727A2 (pt) diferenciacao de celulas-tronco embrionarias humanas
AR077767A1 (es) Diferenciacion de celulas madre embrionarias humanas
MX2016015004A (es) Uso de moleculas pequeñas para mejorar la expresion de mafa en celulas endocrinas pancreaticas.
AR091388A1 (es) Diferenciacion de celulas madres embrionicas humanas en celulas endocrinas pancreaticas
AR082821A1 (es) Diferenciacion de las celulas madre pluripotentes
BR112012017761A2 (pt) diferenciação das células-tronco embrionárias humanas
MX2016017317A (es) Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso.
AR078805A1 (es) Celulas madre pluripotentes
PH12014501175A1 (en) Medium composition for rejuvenating stem cells
AR076648A1 (es) Celulas reversiblemente inmortalizadas asi como metodos relacionados
UY34976A (es) Formas sólidas de un compuesto antiviral
WO2014072720A3 (en) Cell differentiation
WO2013176538A3 (en) Tenogenic medium for mesenchymal stem cells differentation into tenogenic lineage
AR101442A1 (es) Método para la expansión de células madre de adultos de sangre
AR080086A1 (es) Diferenciacion de celulas madre embrionarias humanas
TH141655A (th) การเปลี่ยนแปลงของสเต็มเซลล์จากตัวอ่อนมนุษย์ไปเป็นเซลล์ที่ทำหน้าที่จำเพาะ
AR080087A1 (es) Metodo para promover la diferenciacion de celulas madre embrionarias humanas

Legal Events

Date Code Title Description
FB Suspension of granting procedure